Paediatric Drug Development  9th December 2015, London, United Kingdom

The Masterclass will focus on how clinical expertise and leadership, alongside the involvement of children and families, can improve the design of, and facilitate the delivery of paediatric medicines research. This will be demonstrated by national and international models of network support, and across a broad spectrum of paediatric conditions, and will provide an overview of key global initiatives available within paediatrics.

Global drug development is changing as paediatric drug development has become an essential part of it, the need to obtain paediatric information for medicines used in children being a consensus in EU and EU with established permanent paediatric regulations requiring early planning and regulatory submissions, and a new paradigm is now emerging i.e. protecting children through clinical research.